Related Experiment Video
Updated: Jul 13, 2026

Multi-target Parallel Processing Approach for Gene-to-structure Determination of the Influenza Polymerase PB2 Subunit
Published on: June 28, 2013
iBRAB: In silico based-designed broad-spectrum Fab against H1N1 influenza A virus
Phuc-Chau Do1,2, Trung H Nguyen1,2, Uyen H M Vo1,2
1School of Biotechnology, International University, Thu Duc District, Hochiminh City, Vietnam.
Scientists developed a computational method, iBRAB, to design a broad-reactive antibody fragment (Fab) effective against diverse Influenza A virus strains. This approach accelerates the creation of potential broad-spectrum vaccines for influenza.
Area of Science:
- Virology
- Immunology
- Computational Biology
Background:
- Influenza A virus causes global epidemics and seasonal illnesses, leading to millions of deaths.
- Developing broad-spectrum vaccines against influenza is crucial for pandemic preparedness.
- Computational methods offer a faster approach to vaccine design.
Purpose of the Study:
- To develop an in silico protocol (iBRAB) for designing broad-reactive antibody fragments (Fabs) against Influenza A virus.
- To create a vaccine candidate with activity against a wide range of Influenza A virus strains.
- To leverage computational tools for rapid vaccine development.
Main Methods:
- Developed the iBRAB in silico protocol for designing Fabs.
- Constructed the Fab model using sequences and structures of existing broad-spectrum antibodies against H1N1.
- Utilized computational tools for accelerated examination and validation.
Main Results:
- The iBRAB protocol successfully designed a Fab model with good binding affinity.
- The model demonstrated binding to 27 selected Hemagglutinins (HAs) from various H1N1 strains, including wild-type and mutated variants.
- Computational examination confirmed the model's efficacy.
Conclusions:
- The iBRAB protocol provides an efficient method for designing broad-reactive Fabs against Influenza A.
- This computational approach can accelerate the development of therapeutic vaccines for influenza and other viral threats.
- The designed Fab shows promise as a component of a broad-spectrum influenza vaccine.
More Related Videos
12:18Expression of Functional Recombinant Hemagglutinin and Neuraminidase Proteins from the Novel H7N9 Influenza Virus Using the Baculovirus Expression System
Published on: November 6, 2013
09:07Using Zebrafish Models of Human Influenza A Virus Infections to Screen Antiviral Drugs and Characterize Host Immune Cell Responses
Published on: January 20, 2017
Related Concept Videos
Production of Pharmaceuticals
Influenza
Inhibitors of Bacterial Protein Synthesis
Inhibitors of Viral Protein Synthesis
Inhibitors Of Virion Release
Inhibitors of Virion Maturation and Assembly